MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, APRE has $47,612,387 in assets. $46,466,202 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
891.99%
Quick Ratio
891.99%
Cash Ratio
877.28%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Other noncurrent assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accumulated other comprehensive ...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
46,466,202 14,599,347 13,718,052 16,532,199
Prepaid expenses and other current assets
779,238 961,899 225,936 395,011
Total current assets
47,245,440 15,561,246 13,943,988 16,927,210
Property and equipment, net
54,379 59,807 65,236 70,665
Restricted cash
41,406 41,186 40,930 40,673
Other noncurrent assets
271,162 271,162 271,162 271,162
Total assets
47,612,387 15,933,401 14,321,316 17,309,710
Accounts payable
2,940,756 713,668 641,322 1,195,838
Accrued expenses
2,355,890 2,050,690 2,039,785 1,971,830
Total current liabilities
5,296,646 2,764,358 2,681,107 3,167,668
Series a convertible preferred stock, 0.001 par value, 40,000,000 shares authorized 31,194 shares issued and outstanding at march 31, 2026 and december 31, 2025
727,361 727,361 727,361 727,361
Common stock, 0.001 par value, 400,000,000 shares authorized, 11,982,776 and 8,192,538 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
11,983 8,192 5,979 5,752
Additional paid-in capital
389,631,454 356,709,645 352,722,214 352,250,747
Subscription receivable
499,999 ---
Accumulated other comprehensive loss
-10,625,700 -10,634,714 -10,629,534 -10,628,417
Accumulated deficit
-336,929,358 -333,641,441 -331,185,811 -328,213,401
Total stockholders' equity
41,588,380 12,441,682 10,912,848 13,414,681
Total liabilities and stockholders' equity
47,612,387 15,933,401 14,321,316 17,309,710
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$46,466,202 Prepaid expenses andother current assets$779,238 Total current assets$47,245,440 Other noncurrentassets$271,162 Property and equipment,net$54,379 Restricted cash$41,406 Total assets$47,612,387 Total liabilities andstockholders' equity$47,612,387 Total stockholders'equity$41,588,380 Total currentliabilities$5,296,646 Series a convertiblepreferred stock, 0.001 par...$727,361 Accumulated deficit-$336,929,358 Accumulated othercomprehensive loss-$10,625,700 Subscription receivable$499,999 Additional paid-in capital$389,631,454 Accounts payable$2,940,756 Accrued expenses$2,355,890 Common stock, 0.001 parvalue, 400,000,000...$11,983

Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics, Inc. (APRE)